Biotech
Aug. 11, 2011
Kate H. Murashige
Murashige is working on patents for companies developing various cancer treatments and even a cancer vaccine.
Her client Celator Pharmaceuticals Corp., headquartered in Canada, is patenting technology that improves combination drug therapy for cancer patients.
Murashige also represents South San Francisco-based Trellis Bioscience Inc. on patents for vaccines that prevent the flu and respiratory syncytial virus, which affects infants. <...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In